Drug name - Zontivity

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7713999 XSPIRE PHARMA Thrombin receptor antagonists
May, 2024

(1 year, 5 months from now)

US7304078 XSPIRE PHARMA Thrombin receptor antagonists
Dec, 2027

(5 years from now)

Drugs and Companies using VORAPAXAR SULFATE ingredient

Market Authorisation Date: 08 May, 2014

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 2.08MG BASE TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in